Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-01 @ 1:13 AM
Study NCT ID:
NCT00429793
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2007-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: